BioSenic S.A. (BIOS) - Total Liabilities

Latest as of June 2025: €28.10 Million EUR ≈ $32.85 Million USD

Based on the latest financial reports, BioSenic S.A. (BIOS) has total liabilities worth €28.10 Million EUR (≈ $32.85 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore BioSenic S.A. (BIOS) investment intensity to see how much of total assets are deployed in long-term investments.

BioSenic S.A. - Total Liabilities Trend (2011–2024)

This chart illustrates how BioSenic S.A.'s total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see BIOS current and non-current assets.

BioSenic S.A. Competitors by Total Liabilities

The table below lists competitors of BioSenic S.A. ranked by their total liabilities.

Company	Country	Total Liabilities
Lazydays Holdings Inc NASDAQ:GORV	USA	$359.47 Million
Triangle Energy (Global) Ltd AU:TEG	Australia	AU$20.25 Million
Phoenix Spree Deutschland Ltd LSE:PSDL	UK	GBX315.43 Million
Reinhold Europe AB WAR:RHD	Poland	zł2.15 Million
Impax Asset Management Group Plc LSE:IPX	UK	GBX39.48 Million
TNL Mediagene Ordinary Shares NASDAQ:TNMG	USA	$49.03 Million
Integrated Media Technology Ltd NASDAQ:IMTE	USA	$1.99 Million
Castings PLC LSE:CGS	UK	GBX40.76 Million

Liability Composition Analysis (2011–2024)

This chart breaks down BioSenic S.A.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See BIOS net asset quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.53	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-1.19	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	6.24	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how BioSenic S.A.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for BioSenic S.A. (2011–2024)

The table below shows the annual total liabilities of BioSenic S.A. from 2011 to 2024.

Year	Total Liabilities	Change
2024-12-31	€31.55 Million ≈ $36.89 Million	-2.21%
2023-12-31	€32.26 Million ≈ $37.72 Million	+23.15%
2022-12-31	€26.20 Million ≈ $30.63 Million	-1.27%
2021-12-31	€26.54 Million ≈ $31.02 Million	+23.37%
2020-12-31	€21.51 Million ≈ $25.15 Million	+5.73%
2019-12-31	€20.34 Million ≈ $23.79 Million	-4.31%
2018-12-31	€21.26 Million ≈ $24.86 Million	-6.70%
2017-12-31	€22.79 Million ≈ $26.64 Million	-2.25%
2016-12-31	€23.32 Million ≈ $27.26 Million	+4.85%
2015-12-31	€22.24 Million ≈ $26.00 Million	-33.99%
2014-12-31	€33.69 Million ≈ $39.38 Million	+164.25%
2013-12-31	€12.75 Million ≈ $14.90 Million	+8.22%
2012-12-31	€11.78 Million ≈ $13.77 Million	+4.79%
2011-12-31	€11.24 Million ≈ $13.14 Million	--

About BioSenic S.A.

BR:BIOS Belgium Biotechnology

Market Cap

$1.68 Million

€1.44 Million EUR

Market Cap Rank

#30335 Global

#110 in Belgium

Share Price

€0.00

Change (1 day)

+0.00%

52-Week Range

€0.00 - €0.00

All Time High

€20.66